Cranial Stabilization Devices Market to Witness Upward Trend with Approval of Spinal Stabilization System

The cranial stabilization devices market is expected to witness significant growth in the foreseeable future due to various factors such as high incidence of neurological disorders, increasing geriatric population, and high number of emergency surgeries.

Impact of Neurological Disorders on Cranial Stabilization Devices Market Growth

Neurological disorders include, acute spinal cord injury, Alzheimer's disease, brain tumors, cerebral aneurysm, epilepsy, and others. Cranial stabilization devices are designed for patient positioning in the prone, supine, and sitting positions during surgeries involving the brain and neck. According to Alzheimer’s Association, around 5.8 million people in the U.S. aged 65 and older are living with Alzheimer's dementia in 2020. Such trend suggests high demand for cranial stabilization devices in North America.

The U.S is also witnessing high incidence of brain tumor. According to The Central Brain Tumor Registry of the United States (2020 CBTRUS Statistical Report), the incidence rate of all primary malignant and non-malignant brain and other central nervous system tumors in the U.S was 23.79 cases per 100,000 for a total count of 415,411 incident tumors. Such trend suggests high demand for cranial stabilization devices in the U.S.

Relation between Growing Geriatric Population and Growth of Cranial Stabilization Devices Market

Geriatric population is prone to various orthopedic and neurological diseases that involve use of cranial stabilization devices. According to United Nations Population Fund, geriatric population in Asia Pacific is expected to triple between 2010 and 2050 to reach 1.3 billion people by 2050. This also suggests significant demand for cranial stabilization devices in Asia Pacific.

Geriatric population, as earlier mentioned, is vulnerable to orthopedic diseases. Treatment of such diseases may require the use of cranial stabilization devices. According to researchers at the National Spinal Cord Injury Statistical Center at University of Alabama at Birmingham, as of 2019, 17,730 new spinal cord injury cases occur annually and between 249,000 and 363,000 people are currently living with spinal cord injuries in the U.S.

New Developments in Cranial Stabilization Devices Market

In November 2020, the U.S. Food and Drug Administration gave 510(k) clearance to SeaSpine Holdings Corporation's Mariner Cap System that is used to offer temporary stabilization as a bone anchor during the development of solid bony fusion and aid in the repair of bone fractures. SeaSpine Holdings Corporation is a U.S.-based manufacturer of surgical solutions for the treatment of patients suffering from spinal disorders.

Comments

The Global Pressure Bandages Market Is Witnessing High Growth Owing To the Increasing Incidence of Surgical Processes in the World

Market Overview: During a medical emergency, a pressure bandage is used to apply pressure to an area of the body to control bleeding and swelling. There are a variety of types of pressure bandages that can be used for different purposes. The bandage is made up of several parts, including an air bladder, a pad, a closure bar, and an applicator. A pressure bandage can be applied to wounds at any location on the body. This type of dressing is useful in treating various conditions, including gunshot wounds. It can also be used for a temporary holding of a hernia. The bandage is usually vacuum-sealed, so it's easier to carry. Competitive Landscape: Major players operating in the global pressure bandages market include ConvaTec Group PLC., Cardinal Health, 3M, B. Braun Melsungen AG, Lohmann & Rauscher GmbH & Co. KG, Mölnlycke Health Care AB, Smith & Nephew plc., Paul Hartmann AG, and Essity (BSN medical GmbH). Key Market Drivers: Increasing developments by key pla...

Increasing Incidences of Infectious Diseases to Augment the Antibacterial Drugs Market Growth

Antibacterial drugs are widely used to treat and prevent infectious diseases and are categorized into seven major classes, such as β-Lactams, phenicols, macrolides, quinolones, sulfonamides, tetracyclines, and aminoglycosides, based on their molecular structure. Antibacterial drugs destroy or slow down the growth of bacteria. These medications are also used to treat urinary infections caused by S. aureus, E. coli, Streptococcus pyogenes, and other bacterial infections. They include a range of powerful drugs used to treat diseases caused by bacteria. Antibiotics cannot treat viral infections, such as cold, flu, and most coughs. Antibacterial drugs play a major role in advanced healthcare, as they are widely used to treat infectious diseases, such as tuberculosis, malaria, typhoid, leprosy, hepatitis B, HIV/AIDS, and others. Thus, there is an increasing demand for antibacterial drugs worldwide.

Fc Protein and Glycoengineered Antibodies Market Is Booming Worldwide 2023-2028

Global Fc Protein and Glycoengineered Antibodies Market Drivers Key players in the market are focusing on research and development activities and receiving approvals from regulatory bodies, which are expected to boost the global Fc protein and glycoengineered antibodies market growth over the forecast period. For instance, in 2016, Genentech Inc. received approval from the U.S. Food and drug Administration (U.S. FDA) for Tecentriq (Atezolizumab). It is being used for the treatment of urothelial carcinoma. In March 2019, Tecentriq received its second approval from the U.S. FDA for the treatment of small lung cancer. Furthermore, in November 2017, TG Therapeutics, Inc. began its clinical trial of Ublituximab for the treatment of multiple sclerosis. It is currently in third phase of its clinical trial. Factors such as increasing product approvals and robust pipeline are expected to drive the global fc protein and glycoengineered antibodies market growth. Increasing preva...

Healthcare News

Search This Blog